The ongoing stability program for a drug was inadequate.
Inspection Record
Altius Healthcare Inc. — Health Canada Inspection Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
The quality control department did not evaluate the results of the annual product quality review.
Investigations into deviations, reports, and/or follow-up actions were inadequate.
The quality control department's handling of complaints and/or information received about drug quality was inadequate.
The training of personnel in good manufacturing practices and/or the maintenance of records was inadequate. The job descriptions for personnel, the authority given to personnel, and/or the delegation of duties was inadequate and/or undocumented.
About this record
Extracted automatically from the document of the Health Canada inspection on 2026-05-05. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
